Meeting slides
Suggested Readings

Asthma biologics: real-world effectiveness, impact of switching biologics, and predictors of response.

Abbas F, et al. Ann Allergy Asthma Immunol. 2021. [Epub ahead of print.]

EAACI biologicals guidelines – recommendations for severe asthma.

Agache I, et al. Allergy. 2021;76(1):14-44.

Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.

Busse WW, et al. Am J Respir Crit Care Med. 2013;188(11):1294-1302.

Mastinib significantly decreases the rate of asthma exacerbations in patients with severe asthma uncontrolled by oral corticosteroids: a phase 3 multicenter study.

Chanez P, et al. Am J Respir Crit Care Med. 2020;201:A4210.

What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance.

Clark VL, et al. ERJ Open Res. 2021;7(1):00497-2020.

New targeted therapies for uncontrolled asthma.

Corren J. J Allergy Clin Immunol Pract. 2019;7(5):1394-1403

T2-“low” asthma: overview and management strategies.

Fitzpatrick AM, et al. J Allergy Clin Immunol Pract. 2020;8(2):452-463.

Treatment options in type-2 low asthma.

Hinks TSC, et al. Eur Respir J. 2021;57(1):2000528.

Tezepelumab in adults and adolescents with severe, uncontrolled asthma.

Menzies-Gow A, et al. N Engl J Med. 2021;384(19):1800-1809.

Oral corticosteroid exposure and adverse effects in asthmatic patients.

Sullivan PW, et al. J Allergy Clin Immunol. 2018;141(1):110-116.e7.

Linked Resources

Clinical Practice Guidelines

Global Strategy for Asthma Management and Prevention.

Global Initiative for Asthma, 2021.

Clinical Practice Tools

Centers for Disease Control and Prevention (CDC) Asthma Action Plans

These tools for asthma control were created following the evidence-based guidance published by the National Institutes of Health.   

Asthma Control Test (ACT)

This 5-question test evaluates asthma control over the past 4 weeks on a 5-point Likert scale. A score of <20 on the ACT suggests asthma that is uncontrolled.

Nathan RA, et al. J Allergy Clin Immunol. 2004;113(1):59-65.

Asthma Control Questionnaire (ACQ)

This 7-question assessment tool measures asthma control over the past 7 days. Six questions are self-administered by the patient, and 1 question requires a clinician’s input. Scores range from 1 (totally controlled) to 6 (severely uncontrolled).

Juniper EF, et al. Eur Respir J. 1999;14(4):902-907.

Asthma Therapy Assessment Questionnaire (ATAQ)

This 4-question test assesses asthma control over the past 4 weeks. Each question has a possible score of 0 or 1; if the sum of the 4 question scores is >1, the patient’s asthma may be uncontrolled.

Vollmer WM, et al. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1647-1652.

Shared Decision-Making Tool

The CHEST Foundation, Allergy and Asthma Network, and American College of Allergy, Asthma & Immunology (ACAAI) have developed a shared decision-making tool for adults with severe asthma so that they may work collaboratively with clinicians to improve self-management skills, choose the best treatment plan, and increase adherence.

Patient Advocacy Organizations and Resources

Asthma and Allergy Foundation of America (AAFA)

AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy, and research.

American College of Allergy, Asthma & Immunology (ACAAI)

The ACAAI fosters a culture of collaboration and congeniality in which members work toward the common goals of patient care, education, advocacy, and research.

American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research.

American Thoracic Society (ATS)

The mission of the ATS is to improve health worldwide by advancing research, clinical care, and public health in respiratory disease, critical illness, and sleep disorders.

Chest Foundation

The CHEST Foundation creates trusted patient education resources and disease awareness campaigns that empower patients to engage in better managing their health.

Related activities
1.00 CME/CE

Cause for Alarm

New Avenues to the Management of Severe Asthma

Faculty: Reynold A. Panettieri, Jr, MD; Monica Kraft, MD; Anju T. Peters, MD, MS
Release: 01/18/2022
Expiration: 01/18/2023